Big Pharma Improves Access to Medicine in Developing World

SOURCE: Justmeans


The Access to Medicine Foundation has released its 2012 Access to Medic Index (ATM Index). The ATM Index is designed to provide independent, unbiased and credible information regarding individual pharmaceutical companies' progress on making drugs and other medical products more available and affordable in developing countries.

"We are publishing the Index for the third time," said Wim Leereveld, CEO of the Access to Medicine Foundation, "and it has matured to the point that we are now able to provide some robust trend analysis on how individual companies, and the industry as a whole, are evolving their approach to access to medicine."

The ATM Index ranks the top 20 pharmaceutical companies on their efforts to provide greater access to medicine. Topping the list this year is London-based GlaxoSmithKline (NYSE:GSK), which also led the rankings the previous two times they were published, in 2008 and 2010.

Click here to continue reading and comment

Harry Stevens is a freelance reporter covering climate change, corporate social responsibility, social enterprise, and sustainable finance. Harry has contributed to several media outlets, including Justmeans, GreenBiz, SocialEarth, and Sustainablog. You can follow Harry on Twitter: @Harry_Stevens

Tweet me: .@GSKUS tops 2012 ATM Index making products more affordable to developing countries #csr

KEYWORDS: 2012 Access to Medic Index, csr, developing countries, Medicine, sustainability, GlaxoSmithKline

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here